@article{2abf0837a83343c2836d420c71af7c30,
title = "Local treatment with electrochemotherapy of superficial angiosarcomas: Efficacy and safety results from a multi-institutional retrospective study",
abstract = "Background: Angiosarcoma is an aggressive vascular neoplasm with a high propensity for local recurrence. Electrochemotherapy is an emerging skin-directed therapy, exerting prominent cytotoxic activity, and antivascular effects. Its efficacy in angiosarcoma has not been investigated. Methods: This multicenter retrospective analysis reviewed patients who underwent electrochemotherapy from 2007 to 2014 for superficial advanced angiosarcomas. Bleomycin was administered intravenously and delivered within tumors by means of percutaneously applied electric pulses, according to the European Standard Operating Procedures for Electrochemotherapy. Tumor assessment was performed using RECIST (version 1.1). Toxicity (CTCAE, v4.0) and local progression-free survival (LPFS) were also evaluated. Results: Nineteen patients (13 with locally advanced and 6 with metastatic angiosarcomas) were treated. Tumor sites were: scalp (n = 5), breast (n = 8), other skin sites (n = 3), and soft tissue (n = 3). Target lesions (n = 54) ranged in size from 1.5 to 2.5 cm (median, 2 cm). Treatment was well tolerated. After 2 months, an objective response was observed in 12/19 (63%) patients, complete in 8 (42%). One-year LPFS within treatment field was 68%. Local symptom improvement included palliation of bleeding (5/19 patients) and pain relief (6/19 patients). Conclusions: Electrochemotherapy may represent a new locoregional treatment for selected patients with superficial angiosarcomas. J. Surg. Oncol. 2016;114:246–253. {\textcopyright} 2016 Wiley Periodicals, Inc. {\textcopyright} 2016 Wiley Periodicals, Inc.",
keywords = "bleomycin, drug delivery systems, electrochemotherapy, hemangiosarcoma, local, neoplasm recurrence, vascular neoplasms",
author = "M. Guida and Campana, {L. G.} and Paolo Curatolo and Sabino Strippoli and A. Bonadies and G. Grilz and Carlo Cabula and R. Rotunno and S. Bucher and Nicola Solari and A. Santoriello and Sara Valpione and C. Rossi",
note = "Cited By :1 Export Date: 16 March 2017 CODEN: JSONA Correspondence Address: Campana, L.G.; Veneto Institute of Oncology IOV-IRCCSItaly; email: maximizing@hotmail.com References: Young, R.J., Brown, N.J., Reed, M.W., Angiosarcoma (2010) Lancet Oncol, 11, pp. 983-991; Koch, M., Nielsen, G.P., Yoon, S.S., Malignant tumors of blood vessels: Angiosarcomas, hemangioendotheliomas, and hemangioperictyomas (2008) J Surg Oncol, 97, pp. 321-329; Mark, R.J., Poen, J.C., Tran, L.M., Angiosarcoma. A report of 67 patients and a review of the literature (1996) Cancer, 77, pp. 2400-2406; Fayette, J., Martin, E., Piperno-Neumann, S., Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: A retrospective study of 161 cases (2007) Ann Oncol, 18, pp. 2030-2036; Albores-Saavedra, J., Schwartz, A.M., Henson, D.E., Cutaneous angiosarcoma. Analysis of 434 cases from the surveillance, epidemiology, and end results program, 1973–2007 (2011) Ann Diagn Pathol, 15, pp. 93-97; Salas, S., Stoeckle, E., Collin, F., Superficial soft tissue sarcomas (S-STS): A study of 367 patients from the French Sarcoma Group (FSG) database (2009) Eur J Cancer, 45, pp. 2091-2102; Rossi, C.R., Vecchiato, A., Mastrangelo, G., Adherence to treatment guidelines for primary sarcomas affects patient survival: A side study of the European CONnective TIssue CAncer NETwork (CONTICANET) (2013) Ann Oncol, 24, pp. 1685-1691; Maddox, J.C., Evans, H.L., Angiosarcoma of skin and soft tissue: A study of forty-four cases (1981) Cancer, 48, pp. 1907-1921; Pawlik, T.M., Paulino, A.F., McGinn, C.J., Cutaneous angiosarcoma of the scalp: A multidisciplinary approach (2003) Cancer, 98, pp. 1716-1726; Ogawa, K., Takahashi, K., Asato, Y., Treatment and prognosis of angiosarcoma of the scalp and face: A retrospective analysis of 48 patients (2012) Br J Radiol, 85, pp. e1127-e1133; Jallali, N., James, S., Searle, A., Surgical management of radiation-induced angiosarcoma after breast conservation therapy (2012) Am J Surg, 203, pp. 156-161; Torres, K.E., Ravi, V., Kin, K., Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancer (2013) Ann Surg Oncol, 20, pp. 1267-1274; Morgan, E.A., Kozono, D.E., Wang, Q., Cutaneous radiation-associated angiosarcoma of the breast: Poor prognosis in a rare secondary malignancy (2012) Ann Surg Oncol, 19, pp. 3801-3808; Seinen, J.M., Styring, E., Verstappen, V., Radiation-associated angiosarcoma after breast cancer: High recurrence rate and poor survival despite surgical treatment with R0 resection (2012) Ann Surg Oncol, 19, pp. 2700-2706; Abraham, J.A., Hornicek, F.J., Kaufman, A.M., Treatment and outcome of 82 patients with angiosarcoma (2007) Ann Surg Oncol, 14, pp. 1953-1967; Penel, N., Marreaud, S., Robin, Y.M., Angiosarcoma: State of the art and perspectives (2011) Crit Rev Oncol Hematol, 80, pp. 257-263; Ducimetiere, F., Lurkin, A., Ranchere-Vince, D., Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing (2011) PLoS ONE, 6; Mir, L.M., Orlowski, S., Mechanisms of electrochemotherapy (1999) Adv Drug Deliv Rev, 35, pp. 107-118; Sersa, G., Jarm, T., Kotnik, T., Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma (2008) Br J Cancer, 98, pp. 388-398; Jarm, T., Cemazar, M., Miklavcic, D., Antivascular effects of electrochemotherapy: Implications in treatment of bleeding metastases (2010) Expert Rev Anticancer Ther, 10, pp. 729-746; Gehl, J., Geertsen, P.F., Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy (2000) Melanoma Res, 10, pp. 585-589; Curatolo, P., Quaglino, P., Marenco, F., Electrochemotherapy in the treatment of Kaposi sarcoma cutaneous lesions: A two-center prospective phase II trial (2012) Ann Surg Oncol, 19, pp. 192-198; Mir, L.M., Sersa, G., Standard operating procedures of electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by means of invasive or non-invasive electrodes (2006) Eur J Cancer Suppl, 4, pp. 14-25. , GJ; Eisenhauer, E.A., Therasse, P., Bogaerts, J., New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) (2009) Eur J Cancer, 45, pp. 228-247; Lahat, G., Dhuka, A.R., Lahat, S., Outcome of locally recurrent and metastatic angiosarcoma (2009) Ann Surg Oncol, 16, pp. 2502-2509; de Jong, M.A., Oldenborg, S., Oei, B., Reirradiation and hyperthermia for radiation-associated sarcoma (2012) Cancer, 118, pp. 180-187; Campana, L.G., Testori, A., Mozzillo, N., Treatment of metastatic melanoma with electrochemotherapy (2014) J Surg Oncol, 109, pp. 301-307; Quaglino, P., Matthiessen, L.W., Curatolo, P., Predicting patients at risk for pain associated with electrochemotherapy (2015) Acta Oncol, 54, pp. 298-306; Italiano, A., Cioffi, A., Penel, N., Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas (2012) Cancer, 118, pp. 3330-3336; Agulnik, M., Yarber, J.L., Okuno, S.H., An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas (2013) Ann Oncol, 24, pp. 257-263; Hata, M., Wada, H., Ogino, I., Radiation therapy for angiosarcoma of the scalp: Treatment outcomes of total scalp irradiation with X-rays and electrons (2014) Strahlenther Onkol, 90, pp. 899-904; Ohguri, T., Imada, H., Nomoto, S., Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy (2005) Int J Radiat Oncol Biol Phys, 61, pp. 1446-1453; Miki, Y., Tada, T., Kamo, R., Single institutional experience of the treatment of angiosarcoma of the face and scalp (2013) Br J Radiol, 86, p. 20130439; Fujii, H., Arakawa, A., Utsumi, D., CD8+ tumor-infiltrating lymphocytes at primary sites as a possible prognostic factor of cutaneous angiosarcoma (2014) Int J Cancer, 34, pp. 2393-2402; Quaglino, P., Osella-Abate, S., Marenco, F., FoxP3 expression on melanoma cells is related to early visceral spreading in melanoma patients treated by electrochemotherapy (2011) Pigment Cell Melanoma Res, 24, pp. 734-736; Cabula, C., Campana, L.G., Grilz, G., Electrochemotherapy in the treatment of cutaneous metastases from Breast cancer: A multicenter cohort analysis (2015) Ann Surg Oncol, 3, pp. 442-450",
year = "2016",
doi = "10.1002/jso.24287",
language = "English",
volume = "114",
pages = "246--253",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "John Wiley and Sons Inc.",
number = "2",
}